CDC25C and prostate cancer: For the first time, our study elucidated a unique molecular mechanism of action of SD-208 through induction of p21 along with increased phosphorylation of Cdc2 and Cdc25C, which contributed to G2/M arrest in prostate cancer cell proliferation.